Cite
HARVARD Citation
Lam, K. et al. (2017). Development and preclinical studies of 64Cu-NOTA-pertuzumab F(ab′)2 for imaging changes in tumor HER2 expression associated with response to trastuzumab by PET/CT. MAbs. 9 (1), pp. 154-164. [Online].